Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia

Hajime Tamai, O. Mizuno, A. Takaki, K. Kiyohara, G. Komaki, S. Matsubayashi, K. Kuma, L. F. Kumagai, S. Nagataki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Since the secretion of PRL is regulated by the hypothalamic-pituitary axis, an increase in large molecular size PRL in the serum is most likely due to secretion by the pituitary itself. The present study was performed to investigate the possible occurrence of PRL heterogeneity in 128 subjects with menstrual disorder in conjunction with hyperthyroxinemia (88 with untreated Graves’ disease, 40 with subacute thyroiditis) and 50 age- and sex-matched healthy controls. All 128 patients in this study were suffering from amenorrhea or oligomenorrhea at the time of their initial visit. PRL heterogeneity was found in the sera of 5 of 88 (5.7%) patients with untreated Graves’ disease, in 2 of 40 (5.0%) patients with subacute thyroiditis, but in none of the normal controls. PRL heterogeneity remained essentially unchanged in patients with Graves’ disease over 6 months of treatment; however, in patients with subacute thyroiditis, either big-big PRL or big PRL decreased significantly along with a corresponding increase in little PRL associated with recovery from the illness within 6 months. The menstrual disorders in all patients were restored to normal after restoration to a euthyroid state. The underlying cause of the occurrence of PRL heterogeneity in patients with menstrual disorder in conjunction with hyperthyroxinemia is not known.

Original languageEnglish
Pages (from-to)679-684
Number of pages6
JournalJournal of Endocrinological Investigation
Volume14
Issue number8
DOIs
Publication statusPublished - Sep 1991

Fingerprint

Hyperthyroxinemia
Prolactin
Subacute Thyroiditis
Serum
Graves Disease
Oligomenorrhea
Amenorrhea

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia. / Tamai, Hajime; Mizuno, O.; Takaki, A.; Kiyohara, K.; Komaki, G.; Matsubayashi, S.; Kuma, K.; Kumagai, L. F.; Nagataki, S.

In: Journal of Endocrinological Investigation, Vol. 14, No. 8, 09.1991, p. 679-684.

Research output: Contribution to journalArticle

Tamai, H, Mizuno, O, Takaki, A, Kiyohara, K, Komaki, G, Matsubayashi, S, Kuma, K, Kumagai, LF & Nagataki, S 1991, 'Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia', Journal of Endocrinological Investigation, vol. 14, no. 8, pp. 679-684. https://doi.org/10.1007/BF03347893
Tamai, Hajime ; Mizuno, O. ; Takaki, A. ; Kiyohara, K. ; Komaki, G. ; Matsubayashi, S. ; Kuma, K. ; Kumagai, L. F. ; Nagataki, S. / Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia. In: Journal of Endocrinological Investigation. 1991 ; Vol. 14, No. 8. pp. 679-684.
@article{77d618cc67034a4881be120f871c67b9,
title = "Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia",
abstract = "Since the secretion of PRL is regulated by the hypothalamic-pituitary axis, an increase in large molecular size PRL in the serum is most likely due to secretion by the pituitary itself. The present study was performed to investigate the possible occurrence of PRL heterogeneity in 128 subjects with menstrual disorder in conjunction with hyperthyroxinemia (88 with untreated Graves’ disease, 40 with subacute thyroiditis) and 50 age- and sex-matched healthy controls. All 128 patients in this study were suffering from amenorrhea or oligomenorrhea at the time of their initial visit. PRL heterogeneity was found in the sera of 5 of 88 (5.7{\%}) patients with untreated Graves’ disease, in 2 of 40 (5.0{\%}) patients with subacute thyroiditis, but in none of the normal controls. PRL heterogeneity remained essentially unchanged in patients with Graves’ disease over 6 months of treatment; however, in patients with subacute thyroiditis, either big-big PRL or big PRL decreased significantly along with a corresponding increase in little PRL associated with recovery from the illness within 6 months. The menstrual disorders in all patients were restored to normal after restoration to a euthyroid state. The underlying cause of the occurrence of PRL heterogeneity in patients with menstrual disorder in conjunction with hyperthyroxinemia is not known.",
author = "Hajime Tamai and O. Mizuno and A. Takaki and K. Kiyohara and G. Komaki and S. Matsubayashi and K. Kuma and Kumagai, {L. F.} and S. Nagataki",
year = "1991",
month = "9",
doi = "10.1007/BF03347893",
language = "English",
volume = "14",
pages = "679--684",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "8",

}

TY - JOUR

T1 - Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia

AU - Tamai, Hajime

AU - Mizuno, O.

AU - Takaki, A.

AU - Kiyohara, K.

AU - Komaki, G.

AU - Matsubayashi, S.

AU - Kuma, K.

AU - Kumagai, L. F.

AU - Nagataki, S.

PY - 1991/9

Y1 - 1991/9

N2 - Since the secretion of PRL is regulated by the hypothalamic-pituitary axis, an increase in large molecular size PRL in the serum is most likely due to secretion by the pituitary itself. The present study was performed to investigate the possible occurrence of PRL heterogeneity in 128 subjects with menstrual disorder in conjunction with hyperthyroxinemia (88 with untreated Graves’ disease, 40 with subacute thyroiditis) and 50 age- and sex-matched healthy controls. All 128 patients in this study were suffering from amenorrhea or oligomenorrhea at the time of their initial visit. PRL heterogeneity was found in the sera of 5 of 88 (5.7%) patients with untreated Graves’ disease, in 2 of 40 (5.0%) patients with subacute thyroiditis, but in none of the normal controls. PRL heterogeneity remained essentially unchanged in patients with Graves’ disease over 6 months of treatment; however, in patients with subacute thyroiditis, either big-big PRL or big PRL decreased significantly along with a corresponding increase in little PRL associated with recovery from the illness within 6 months. The menstrual disorders in all patients were restored to normal after restoration to a euthyroid state. The underlying cause of the occurrence of PRL heterogeneity in patients with menstrual disorder in conjunction with hyperthyroxinemia is not known.

AB - Since the secretion of PRL is regulated by the hypothalamic-pituitary axis, an increase in large molecular size PRL in the serum is most likely due to secretion by the pituitary itself. The present study was performed to investigate the possible occurrence of PRL heterogeneity in 128 subjects with menstrual disorder in conjunction with hyperthyroxinemia (88 with untreated Graves’ disease, 40 with subacute thyroiditis) and 50 age- and sex-matched healthy controls. All 128 patients in this study were suffering from amenorrhea or oligomenorrhea at the time of their initial visit. PRL heterogeneity was found in the sera of 5 of 88 (5.7%) patients with untreated Graves’ disease, in 2 of 40 (5.0%) patients with subacute thyroiditis, but in none of the normal controls. PRL heterogeneity remained essentially unchanged in patients with Graves’ disease over 6 months of treatment; however, in patients with subacute thyroiditis, either big-big PRL or big PRL decreased significantly along with a corresponding increase in little PRL associated with recovery from the illness within 6 months. The menstrual disorders in all patients were restored to normal after restoration to a euthyroid state. The underlying cause of the occurrence of PRL heterogeneity in patients with menstrual disorder in conjunction with hyperthyroxinemia is not known.

UR - http://www.scopus.com/inward/record.url?scp=0025994593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025994593&partnerID=8YFLogxK

U2 - 10.1007/BF03347893

DO - 10.1007/BF03347893

M3 - Article

C2 - 1774453

AN - SCOPUS:0025994593

VL - 14

SP - 679

EP - 684

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 8

ER -